Core Laboratories N.V. (CLB) has a consensus analyst rating of Hold, based on 37 analysts covering the stock. Of those, 16 recommend buying, 17 recommend holding, and 4 recommend selling.
The analyst consensus price target for CLB is $25.00, representing a +53.7% upside from the current price of $16.27. Price targets range from a low of $17.00 to a high of $32.00.
